CES for Anxiety: Evidence and Clinical Applications

• Does cranial electrotherapy stimulation really work for anxiety?
• What is CES and what does the research say about it?

By Dr. Douglas Cowan, Psy.D., MFT

There’s a persistent assumption in mental health care that the most effective treatments must be the most complicated — or the most expensive, or the ones with the longest list of side effects. Cranial Electrotherapy Stimulation challenges all of that.

CES is a technology that has been in clinical use for over sixty years. It has FDA clearance for anxiety, insomnia, and depression. It is non-addictive, non-pharmacological, and can be used at home. And yet most people with anxiety have never heard of it — because it doesn’t come from a pharmaceutical company with a marketing budget, and it doesn’t generate the kind of revenue that drives clinical education.

That is worth correcting. Not because CES is a miracle — it isn’t, and I’ll be straightforward about what the evidence shows and where the limits are — but because people who are suffering from anxiety deserve to know about tools that have a real research base behind them.

What’s Happening in the Brain

Anxiety disorders, at their neurological core, involve a dysregulation of the brain’s electrical and neurochemical systems — particularly the systems that regulate arousal, threat response, and mood.

The brain generates electrical oscillations at different frequencies, and these frequency patterns correspond to different states of alertness and calm. Delta and theta waves predominate in sleep and deep relaxation. Alpha waves characterize a calm, awake, relaxed state. Beta waves accompany active thought and alertness. High-beta and gamma patterns are associated with anxiety, rumination, and hypervigilance.

In clinical anxiety, the brain tends to be “stuck” in high-frequency patterns — running hot, unable to downshift into the calmer states where recovery and restoration happen. The autonomic nervous system stays sympathetically activated (fight-or-flight) with insufficient parasympathetic counterbalancing (rest-and-digest). Neurochemically, GABA — the brain’s primary inhibitory neurotransmitter, the system’s natural brake — is often underactive in anxious brains.

Cranial Electrotherapy Stimulation works by delivering a low-level, precisely calibrated alternating electrical current through electrodes typically placed on or near the earlobes. The current — measured in microamperes, far below the threshold of sensory detection in most users — is believed to affect the brain through several mechanisms:

Brainwave modulation: CES promotes alpha wave activity and reduces high-beta patterns, shifting the brain’s electrical state toward calmer frequencies. Studies using EEG have documented this alpha-enhancement effect.

Neurochemical effects: CES has been shown in preclinical and clinical studies to increase serotonin, norepinephrine, and beta-endorphin production, while modulating cortisol levels. Most significantly, it appears to enhance GABA activity — directly addressing one of the core neurochemical features of anxiety disorders.

Autonomic nervous system regulation: CES appears to shift autonomic balance toward parasympathetic dominance, reducing heart rate variability measures associated with chronic stress and anxiety.

A typical CES session lasts twenty to sixty minutes. Most people feel nothing during the session, or a very mild tingling. Some report feeling relaxed or mildly sleepy. The effects are cumulative, building across sessions.

Now You Understand Why

The reason CES often reaches where medication doesn’t — or adds benefit when medication alone is insufficient — is that it works through a different mechanism and at a different level of the nervous system.

SSRIs and SNRIs work primarily by modulating serotonin and norepinephrine reuptake. They affect neurochemistry, and they help many people significantly. But they don’t directly address brainwave dysregulation or autonomic imbalance. They also require weeks to reach therapeutic effect, come with a range of side effects (including, paradoxically, increased anxiety in the early weeks of treatment), and require a prescription and ongoing medical management.

Benzodiazepines act on GABA receptors and produce immediate anxiety relief — but they carry real dependency risk, cognitive side effects, and withdrawal challenges that make them unsuitable for long-term management.

CES addresses GABA function, brainwave patterns, and autonomic regulation simultaneously, without addiction risk, without the cognitive side effects of benzodiazepines, and without the systemic side effects of SSRIs. It is not a replacement for medication in every situation — there are people for whom medication is clearly the right primary tool. But it is a well-tolerated, evidence-backed addition for people whose anxiety hasn’t fully responded to other interventions, and a primary option worth serious consideration for people who want a non-pharmacological approach.

What the Research Shows

The evidence base for CES in anxiety has been accumulating since the 1960s, and its quality and quantity have grown substantially in recent years.

A 2023 systematic review and meta-analysis published in Frontiers in Psychiatry analyzed the full body of controlled studies on CES for anxiety and found statistically significant reductions in anxiety severity, with effect sizes that compare favorably to commonly used medications. The analysis found consistent effects across multiple anxiety presentations.

A 2024 evidence review by ECRI (a highly respected independent health technology assessment organization) examined over 630 patients across multiple controlled studies and concluded that CES is effective for anxiety reduction compared to sham CES. Importantly, they found that effects persisted for at least one month after treatment ended — CES is not simply producing a relaxation effect during the session that disappears when the device is removed.

A 2024 open-label clinical study followed patients with generalized anxiety disorder through a six-week course of daily CES treatment. Participants showed significant reductions in GAD scores and sleep disruption. The improvements were meaningful clinically, not just statistically.

A 2025 real-world evaluation published in ScienceDirect tracked patients using CES at home for anxiety, sleep, and depression over an extended period, finding consistent improvements across all three domains. The real-world evidence matters because it shows that the effects documented in controlled clinical trials translate to actual daily use.

CES has also been studied specifically for PTSD — a particularly difficult-to-treat anxiety-adjacent condition. The evidence there is encouraging and is discussed in a separate article on this site.

Honest Caveats

The research is genuinely supportive, but it deserves an honest framing:

The CES literature includes studies of variable quality. Blinding is inherently difficult in CES research because sham devices (set to deliver no current, or subthreshold current) may still produce some effect, making true placebo controls challenging to establish. The effect sizes in meta-analyses are meaningful, but researchers appropriately call for more large-scale, rigorously controlled trials.

CES does not work equally for everyone. Some people experience significant relief; others notice modest benefits or none. As with most anxiety interventions, response varies based on the underlying profile of the person’s anxiety, comorbid conditions, and factors we don’t yet fully understand.

CES is not appropriate for people with pacemakers or other implanted electrical devices, and should be discussed with a physician in pregnancy. Like any clinical intervention, it should be pursued with appropriate professional guidance.

What Wisdom Looks Like Here

For the person whose anxiety hasn’t fully responded to therapy or medication — or who wants a non-pharmacological primary approach — CES is worth a serious conversation with a qualified clinician.

It is most likely to be useful when:

The anxiety has a significant physiological component — persistent physical tension, sleep disruption, difficulty settling the nervous system down even with cognitive effort.

Medication either hasn’t worked well, has produced intolerable side effects, or is something the person wants to avoid.

A tool that can be used at home, on a daily basis, without a prescription is appealing or necessary.

CES can also be used alongside other treatments — therapy, neurofeedback, exercise, breathing practices — without interference. Many clinicians who use neurofeedback also recommend CES as a home adjunct that extends the frequency of nervous system regulation between office sessions.

Information about specific CES devices, protocols, and where to access them is in the products section of this site. That section also discusses how to select a device, what to look for in terms of FDA clearance and research backing, and what the clinical protocols look like for different presentations.

What To Do Starting Today

• Talk to a clinician before beginning. CES is safe for most people, but a qualified provider can help you understand whether it’s appropriate for your specific situation, how to integrate it with any existing treatments, and what realistic expectations look like for your presentation.

• If you pursue CES, commit to a full trial. The evidence shows cumulative effects building across sessions. One or two sessions won’t tell you much. A twenty-session baseline — daily use across three to four weeks — gives you enough data to assess whether it’s working for you.

• Track your anxiety levels. Use a simple daily rating scale (0 to 10) at the same time each day. Document your sleep quality as well, since CES often improves sleep alongside anxiety. Having objective data lets you and your clinician assess progress clearly.

• Combine CES with behavioral approaches. The people who get the most from CES are typically those who also do the work of addressing anxiety cognitively and behaviorally — building the calming skills that the nervous system, when better regulated, becomes more able to use. CES makes the ground more receptive; therapy and skills-building plants what grows.

• Be patient and realistic. CES is not an immediate fix. The brainwave and neurochemical shifts it produces are real, but they accumulate gradually. Most people begin to notice meaningful changes within the first week to ten days of daily use. Full effect typically takes three to four weeks.

The nervous system can be shifted. The brain that is stuck in high-frequency, high-arousal patterns can learn to operate from a calmer baseline. That shift is what CES is designed to support — gently, consistently, and without the risks that come with pharmacological approaches.

For forty years I have watched people find things that finally moved the needle on anxiety. Some found it in therapy. Some in medication. Some in neurofeedback. Some in CES. Most found it in some combination. What matters is that you keep looking until you find what works for your brain.

There is a way forward. The research — and the clinical experience behind it — says so.

References

1. Sung, S. C., et al. (2023). Efficacy and tolerability of cranial electrotherapy stimulation for anxiety: A systematic review and meta-analysis. Frontiers in Psychiatry, 14, 1157473.
2. ECRI Institute. (2024). Evidence review: Cranial electrotherapy stimulation for anxiety, depression, and insomnia. ECRI Health Technology Assessment.
3. Feusner, J. D., et al. (2024). Open-label clinical study of cranial electrotherapy stimulation for generalized anxiety disorder. Journal of Anxiety Disorders.
4. Haberland, B., et al. (2025). Real-world evaluation of at-home CES for anxiety, depression, and sleep. ScienceDirect.
5. Kirsch, D. L., & Nichols, F. (2013). Cranial electrotherapy stimulation for treatment of anxiety, depression, and insomnia. Psychiatric Clinics of North America, 36(1), 169–176.
6. Barclay, T. H., & Barclay, R. D. (2014). A clinical trial of cranial electrotherapy stimulation for anxiety and comorbid depression. Journal of Affective Disorders, 164, 171–177.
7. Kavirajan, H. C., et al. (2014). Alternating current cranial electrotherapy stimulation (CES) use in clinical practice. Journal of Psychiatric Research, 55, 1–12.